^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

SOX10 (SRY-Box 10)

i
Other names: SOX10, SRY-Box 10, SRY-Related HMG-Box Gene 10, Transcription Factor SOX-10, SRY Box 10, WS2E, WS4C
2d
Spitz melanocytoma with AKAP9::BRAF fusion: clinicopathologic and molecular insights. (PubMed, Dermatol Reports)
NGS identified an AKAP9 (exon 32)::BRAF (exon 9) fusion, without TERT promoter mutations or other high-risk alterations. This case highlights a rare molecular subset of Spitz melanocytoma and underscores the importance of integrated molecular and histopathological assessment for accurate diagnosis, prognostic evaluation, and potential targeted therapy.
Journal
|
BRAF (B-raf proto-oncogene) • TERT (Telomerase Reverse Transcriptase) • SOX10 (SRY-Box 10) • PRAME (Preferentially Expressed Antigen In Melanoma) • MLANA (Melan-A)
|
BRAF mutation • BRAF fusion • BRAF rearrangement
3d
Beyond the Skin: A Rare Case of Primary Malignant Melanoma of the Lung. (PubMed, Cureus)
Given the tumour's unresectable nature due to proximity to critical mediastinal structures and the patient's comorbidities, she was initiated on a modified combination immune checkpoint inhibitor regimen with nivolumab and ipilimumab. This case highlights the importance of a meticulous diagnostic approach to solitary pulmonary lesions and underscores the evolving role of immunotherapy in managing rare malignancies such as PMML. Reporting such cases enhances the clinical understanding and guides future management of this rare disease.
Journal • PD(L)-1 Biomarker • IO biomarker
|
BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • SOX10 (SRY-Box 10)
|
BRAF mutation • NRAS mutation • KIT mutation • BRAF wild-type
|
Opdivo (nivolumab) • Yervoy (ipilimumab)
3d
DP20 Soft-tissue perineurioma presenting as a painless nasal papule. (PubMed, Br J Dermatol)
S100, SOX10, neurofilament and desmin are typically negative. While perineuriomas behave in a benign fashion, complete surgical excision is recommended.
Journal
|
CD34 (CD34 molecule) • SOX10 (SRY-Box 10) • MME (Membrane Metalloendopeptidase) • MLANA (Melan-A) • F13A1 (Coagulation Factor XIII A Chain) • SLC2A1 (Solute Carrier Family 2 Member 1)
3d
CPC11 A case of vulval melanosis and depigmentation. (PubMed, Br J Dermatol)
Vulval pigmentation presents a diagnostic challenge, as the features of vulval melanosis can overlap with those of melanoma. This unusual case of a patient with LS, vitiligo and vulval melanosis highlights the importance of taking multiple biopsies in vulval conditions with variable pigmentation to ensure accurate clinicopathological correlation.
Journal
|
SOX10 (SRY-Box 10)
3d
DP07 Clinicopathologic features and outcomes of amelanotic melanoma: a 20-year retrospective case series. (PubMed, Br J Dermatol)
The time from referral to definitive excision was within the national target range, so in this series there was no significant delay to treatment due to misdiagnosis. To minimize diagnostic delays clinicians should maintain a high suspicion for AM in nonpigmented lesions with atypical features, particularly in Fitzpatrick skin types I-II and older patients with chronic photodamage.
Retrospective data • Journal
|
SOX10 (SRY-Box 10)
4d
Expression and role of PD-L1 and SOX10 in hepatocellular carcinoma. (PubMed, Transl Cancer Res)
PD-L1 and SOX10 expression were associated with unfavorable prognostic factors as well as shorter OS and RFS. Further investigation is warranted to elucidate the molecular pathways through which SOX10 may regulate PD-L1 expression and to explore implications for immunotherapy response in patients with HCC.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • SOX10 (SRY-Box 10) • YBX1 (Y-Box Binding Protein 1)
|
PD-L1 expression
7d
Clinicopathological characteristics of cutaneous melanocytic tumor with CRTC1::TRIM11 fusion of three cases (PubMed, Zhonghua Bing Li Xue Za Zhi)
Complete excision with clear margins is recommended. While most of the CMTCTs exhibit indolent biological behaviors, rare cases may recur locally or metastasize, warranting close follow-up.
Journal
|
SOX10 (SRY-Box 10) • MITF (Melanocyte Inducing Transcription Factor) • CRTC1 (CREB Regulated Transcription Coactivator 1)
7d
Oral and Maxillofacial Schwannoma (OMSCH): an institutional study of 102 patients. (PubMed, J Stomatol Oral Maxillofac Surg)
OMSCH is a rare tumor with limited diagnostic accuracy. MRI remains the preferred diagnostic modality, and surgical intervention generally results in favorable outcomes.
Journal
|
SOX10 (SRY-Box 10)
17d
Recurrent melanoma presenting as a rash: a case report. (PubMed, Skin Health Dis)
Here, we describe a case of a woman with stage IIIC melanoma undergoing intralesional talimogene laherparepvec (T-VEC) therapy who developed a spreading erythematous rash on her left leg, accompanied by fatigue and leg swelling. Skin biopsy revealed recurrent melanoma, with SOX10 and Melan-A positivity, and imaging showed features concerning for multifocal disease recurrence in the left popliteal fossa. This case highlights an unusual presentation of melanoma recurrence and underscores the importance of biopsy in -evaluating new skin findings in patients with a history of melanoma.
Journal
|
SOX10 (SRY-Box 10) • MLANA (Melan-A)
|
Imlygic (talimogene laherparepvec)
18d
A Diagnostic Pitfall: Retrocaval Nerve Sheath Tumor. (PubMed, Cureus)
Immunohistochemical staining, crucial for characterizing soft-tissue tumor differentiation, revealed diffuse positivity for SOX10 and S100 protein, consistent with a primary nerve sheath tumor rather than metastatic disease. This case highlights the diagnostic challenge posed by FDG-avid lesions in patients with a history of malignancy, underscoring the importance of considering rare differential diagnoses and pursuing tissue diagnosis when imaging is equivocal or clinical presentation deviates from expected metastatic behavior.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • SOX10 (SRY-Box 10)
20d
Novel susceptibility genes for non-NF2-/LZTR1-/SMARCB1-related hereditary schwannomatosis. (PubMed, Fam Cancer)
In addition, genes such as CDKN2A and SMARCA4 may also contribute to schwannomatosis in the context of broader tumor predisposition syndromes. These emerging genetic associations may help explain a proportion of schwannomatosis cases that currently lack a molecular diagnosis, while there is still room for the discovery of non-coding alleles or mosaic forms of known schwannomatosis-related conditions as well as novel genes that could explain unresolved cases.
Review • Journal
|
CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4) • NF2 (Neurofibromin 2) • SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • SOX10 (SRY-Box 10) • LZTR1 (Leucine Zipper Like Transcription Regulator 1)